PANCAID

🧠 How is AI transforming early cancer detection? 
Join @phireproject.bsky.social, @pancaid.bsky.social, and #PANCAIM on 15 October, 14:00 CEST for a 60-min webinar. 
🔗 Register: https://tinyurl.com/PPPWebinarOnAI 
 
#AI #CancerDiagnosis #Webinar

🚨 New PANCAID Masterclass!
How is #AI transforming pancreatic cancer research?
Dr Núria Malats & Sergio Sabroso (CNIO) explain its role in early detection and #precisiononcology.

▶️ https://youtu.be/H-_Xv3H7fZI
@nuriamalats.bsky.social @cniostopcancer.bsky.social 

#CancerResearch #PancreaticCancer

🎙️Join us for the webinar “Approaches to Early Cancer Diagnosis & the Impact of #AIinOncology” 
🗣️ Moderated by Federica Zanca, EIC Programme Manager 
👥 Panelists: 
@phireproject.bsky.social – Massimo Alfano 
@pancaid.bsky.social  – @nuriamalats.bsky.social 
#PANCAIM – John Hermans 

#Webinar

PHIRE, PANCAID, PANCAIM Approaches to early cancer diagnosis and the impact of artificial intelligence in oncology Register for our webinar 15 October 2025 14:00 - 15:00 CEST Registration link: https://events.teams.microsoft.com/event/1fba7a3a-b605-4bcd-9b99-2076044436a7@ea8b78d9-ccc1-45ec-94de-369c8af49a53 More information: https://pancaid-project.eu/news-events/events/ Funded by the European Union

Join our webinar “Approaches to Early Cancer Diagnosis and the Impact of Artificial Intelligence in Oncology”!
@phireproject.bsky.social, #PANCAIM & @pancaid.bsky.social are proud to discuss how AI is transforming #oncology.

🔗 Register: events.teams.microsoft.com/event/1fba7a...

#CancerResearch

@pancaid.bsky.social is testing the best #liquidbiopsy for the early detection of #pancreaticcancer! Proud to be part of it @ki.se @hpb-karolinska.bsky.social

🚀 Partner spotlight: @zavamed.bsky.social
Leading telehealth platform ensure the readiness for a digital end-to-end patient pathway.
Contributing to:
📍 WP1 – Patient cohort definition & biomaterial collection
📍 WP6 – Dissemination & communication

#HorizonEurope #DigitalHealth #Telemedicine

It’s #RNAday! RNA, especially #microRNA, plays an important role in our research: Part of WP2 is profiling multi-omics data, where we analyse genomic, epigenomic, transcriptomic, microRNA and metabolomic data from #PDAC patients. #pancreaticcancer
➡️ https://pancaid-project.eu/research/work-packages/

Plus we are analysing samples from #pancreaticcancer patients for #extracellularvesicles #EV @danielhagey

🔬 This week’s #PANCAID partner spotlight: @regionstockholm.bsky.social (RS)!

RS contributes to WP1 via Karolinska University Hospital, working with Prof. Löhr's group on clinical recruitment & biobanking.

@hpb-karolinska.bsky.social
@maloehr.bsky.social
@ki.se

#HorizonEurope #CancerResearch

🔦 #PANCAIDPartnerSpotlight: The University of Cambridge (via @cruk-ci.bsky.social) powers WP2 & WP3, and contributes expertise in circulating tumour DNA (ctDNA) analysis and multi-omic data integration.

#CancerResearch #PancreaticCancer #EarlyDetection

🔦 #PANCAIDPartnerSpotlight: FIBIRYCIS brings expertise in #LiquidBiopsy, cancer genetics & PDAC biomarkers to WP1 – supporting sample & data collection across pancreatic lesions.

Part of the Ramón y Cajal Health Research Institute.

#CancerResearch #PancreaticCancer #EarlyDetection

🔦 This week’s #PANCAIDPartnerSpotlight: KSM Innovation / MACCABI

KSM's strengths are:
📊 Access to 30+yrs of digital health data from 2.7M members
🧬 900K biobank samples

In PANCAID, they contribute to WP1 by providing blood samples

#HealthData #CancerDetection #Biobank

🔦 PANCAID Partner Spotlight: @collectiveminds.bsky.social
Co-Leading WP3: Data management & AI 🔍
CMR powers our secure, multimodal data infrastructure:
📊 Repository design
🔐 Privacy & governance

#PANCAID #DataManagement #CancerResearch

🔦 PANCAID Partner Spotlight: @hebrewuniversity.bsky.social
The Dor & Kaplan labs lead epigenetic and ML innovation for PANCAID.

🔬 Dor Group: cfDNA tissue-of-origin via DNA methylation
🧠 Kaplan Group: Multi-omics modeling with advanced machine learning

#CancerDetection #PancreaticCancer

PANCAID coordinator Prof. Klaus Pantel will speak at the G7 Cancer Conference on Poor Prognosis Cancers in Paris, France, on 26th June 2025 More information at g7cancer-events.com

PANCAID is proud to share that coordinator Klaus Pantel will speak at the G7 Cancer conference in Paris on June 26.
🕚 11:50 AM
💬 Talk: Early diagnosis and detection of minimally residual disease in #pancreaticcancer using #liquidbiopsy

More info: g7cancer-events.com

#G7Cancer

🔦 PANCAID Partner Spotlight: @uu.se
The labs of @masoodkamali.bsky.social & @globischlab.bsky.social bring cutting-edge EV, proteomics & metabolomics expertise to PANCAID.
🟣 Working together on biomarker discovery in WP2.

@scilifelab.se
#Metabolomics #CancerResearch

🔦 PANCAID Partner Spotlight: University Hospital Heidelberg (UKHD)
UKHD’s European Pancreas Center (EPZ) provides key biosamples & serum proteomics for PANCAID.
With 10k+ samples in PancoBank, their biobank is critical to early detection research.
#PancreaticCancer #Proteomics

📢 New review from PANCAID's WP4: Cost-effectiveness of #earlydetection in #pancreaticcancer 🧾💶
➡️ Some strategies work well, but inconsistencies in methods limit broader conclusions.

Read the full paper: link.springer.com/article/10.1...

@drchrisbrett.bsky.social
#HealthEconomics

@maloehr.bsky.social @raiheu.bsky.social @nuriamalats.bsky.social @sebens-iet-kiel.bsky.social

🧠 Midpoint check-in!
Today, PANCAID held its 6th Steering Committee meeting as we hit the halfway mark of our #HorizonEU project.
WP leads aligned strategy & next steps for advancing early #PancreaticCancer detection.
We’re buzzing for what’s ahead! ⚡

#CancerResearch #LiquidBiopsy

🔦 PANCAID Partner Spotlight: CHU de Montpellier
At LCCRH, CHUM pioneers CTC research to drive early cancer detection.
They support WP2, WP3 & WP6: from biomarker discovery to data science and training young researchers.
@cathiepana.bsky.social

#LiquidBiopsy #CancerResearch #PancreaticCancer

Today is #WorldDigestiveHealthDay 🟣
PANCAID aims to tackle one of the biggest challenges in digestive health: the late detection of #PancreaticCancer.
We're working on a minimally invasive blood test to catch it early, when it’s still treatable.

#EarlyDetection #CancerResearch

🧬 New research: Fecal #metabolomics reveals key differences between autoimmune & chronic pancreatitis, unlocking potential for novel diagnostics!
📄 Read the study: onlinelibrary.wiley.com/doi/full/10....

@maloehr.bsky.social @globischlab.bsky.social

#PancreaticCancer #Biomarkers #liquidbiopsy

🔦 PANCAID Partner Spotlight: #UKSH
UKSH co-leads WP1 in PANCAID: Defining patient cohorts & guiding biomaterial collection.
With 650+ cancer & 100+ control samples from TRIBanK, they power biomarker discovery for early #pancreaticcancer detection.
@sebens-iet-kiel.bsky.social

Poster of High Level Seminar on Precision Diagnostics for Precision Cancer Care. Subline: Improving Patient Access to Innovation Hosted by MEP Vasile (Vlad) Voiculescu European Parliament - Brussels Room SPAAK 7C50 May 20th, 2025 - 14:00 - 18:00 Organised by EU-funded project Instand-NGS4P

PANCAID Coordinator Prof. Klaus Pantel joins a high-level seminar on #PrecisionDiagnostics & NGS in cancer care, hosted by MEP Vlad Voiculescu, organised by #Instand-NGS4P

The message: We need to accelerate access to innovative diagnostics like #LiquidBiopsy for every patient in 🇪🇺.

🔦 PANCAID Partner Spotlight: @concentris.bsky.social
As project office & WP6 lead, concentris keeps PANCAID running smoothly, from coordination to communication, training & impact.

Their expert team supports EU research from start to finish.
#ResearchManagement #SciComm #HorizonEurope

🔦 PANCAID Partner Spotlight: @pce-europe.bsky.social
PCE co-leads PANCAID's communication & dissemination efforts (WP6), ensuring research reaches patients, policymakers & the public.
Their work unites 80+ European experts to improve survival & awareness.
#PancreaticCancer #Advocacy

Klaus Pantel presented the Young Investigator Award at #ISMRC2025, alongside Catherine Alix-Panabières and Paul Hofman.

It's especially wonderful to see PANCAID members received two silver and one gold award! Heartfelt congratulations for your work
(outside PANCAID)

🧠 “Transforming cancer patient management: the intersection of #AI and #LiquidBiopsy”, Núria Malats explores the perspectives of liquid biopsy at #ISMRC2025.

@nuriamalats.bsky.social

#CancerResearch

🩸🔬 Kicking off the final day at #ISMRC2025:
PANCAID’s WP3 lead Núria Malats ( @nuriamalats.bsky.social from CNIO) moderates today’s session on the latest developments in #LiquidBiopsy

#PANCAID #CancerResearch #EarlyDetection